Distinct Symptom-Specific Treatment Targets for Circuit-Based Neuromodulation
2020/03/12 by Shan Siddiqi, Shan H. Siddiqi, Stephan F. Taylor +6 · 38 citations
Neuroscience · Medicine · #Transcranial Magnetic Stimulation Studies #Functional Brain Connectivity Studies #Electroconvulsive Therapy Studies
paper · doi:10.1176/appi.ajp.2019.19090915
Abstract
OBJECTIVE: Treatment of different depression symptoms may require different brain stimulation targets with different underlying brain circuits. The authors sought to identify such targets, which could improve the efficacy of therapeutic brain stimulation and facilitate personalized therapy. METHODS: The authors retrospectively analyzed two independent cohorts of patients who received left prefrontal transcranial magnetic stimulation (TMS) for treatment of depression (discovery sample, N=30; active replication sample, N=81; sham replication sample, N=87). Each patient's TMS site was mapped to underlying brain circuits using functional connectivity MRI from a large connectome database (N=1,000). Circuits associated with improvement in each depression symptom were identified and then clustered based on similarity. The authors tested for reproducibility across data sets and whether symptom-specific targets derived from one data set could predict symptom improvement in the other independent cohort. RESULTS: The authors identified two distinct circuit targets effective for two discrete clusters of depressive symptoms. Dysphoric symptoms, such as sadness and anhedonia, responded best to stimulation of one circuit, while anxiety and somatic symptoms responded best to stimulation of a different circuit. These circuit maps were reproducible, predicted symptom improvement in independent patient cohorts, and were specific to active compared with sham stimulation. The maps predicted symptom improvement in an exploratory analysis of stimulation sites from 14 clinical TMS trials. CONCLUSIONS: Distinct clusters of depressive symptoms responded better to different TMS targets across independent retrospective data sets. These symptom-specific targets can be prospectively tested in a randomized clinical trial. This data-driven approach for identifying symptom-specific targets may prove useful for other disorders and facilitate personalized neuromodulation therapy.
Cited by
- Functional Connectivity Mapping for rTMS Target Selection in Depression
- Using Brain Imaging to Improve Spatial Targeting of Transcranial Magnetic Stimulation for Depression
- Personalized and Circuit-Based Transcranial Magnetic Stimulation: Evidence, Controversies, and Opportunities
- Dimensional and Categorical Solutions to Parsing Depression Heterogeneity in a Large Single-Site Sample
- Comparing reliability-based measures of functional connectivity between movie and rest: An ROI-based approach
- Translation of network mapping findings into therapeutic targets for transcranial magnetic stimulation
- Network-based near-scalp personalized brain stimulation targets
- Consensus review and considerations on TMS to treat depression: A comprehensive update endorsed by the National Network of Depression Centers, the Clinical TMS Society, and the International Federation of Clinical Neurophysiology
- Antidepressant effects of prolonged intermittent theta-burst stimulation monotherapy at the bilateral dorsomedial prefrontal cortex for medication and standard transcranial magnetic stimulation-resistant major depression: a three arm, randomized, double blind, sham-controlled pilot study
- Investigating the methodological foundation of lesion network mapping
- Neural correlates of peripartum depression: a systematic review, meta-analysis and comparison to major depressive disorder
- Shared but distinct functional connectome profiles underlying rumination in depressed and healthy individuals
- Transcranial magnetic stimulation treatment in Alzheimer’s disease: a meta-analysis of its efficacy as a function of protocol characteristics and degree of personalization
- Opportunities of connectomic neuromodulation. [europepmc]
- Emotion processing and regulation in major depressive disorder: A 7T resting-state fMRI study. [europepmc]
- rTMS modulates precuneus-hippocampal subregion circuit in patients with subjective cognitive decline. [europepmc]
- New approaches to symptomatic treatments for Alzheimer's disease. [europepmc]
- Efficacy of Active vs Sham Intermittent Theta Burst Transcranial Magnetic Stimulation for Patients With Bipolar Depression: A Randomized Clinical Trial. [europepmc]
- Targeting location relates to treatment response in active but not sham rTMS stimulation. [europepmc]
- Targeting neural oscillations with transcranial alternating current stimulation. [europepmc]
- Therapies to Restore Consciousness in Patients with Severe Brain Injuries: A Gap Analysis and Future Directions. [europepmc]
- Brain stimulation and brain lesions converge on common causal circuits in neuropsychiatric disease. [europepmc]
- Reducing the Cognitive Footprint of Brain Tumor Surgery. [europepmc]
- Anatomical and fMRI-network comparison of multiple DLPFC targeting strategies for repetitive transcranial magnetic stimulation treatment of depression. [europepmc]
- Transcranial magnetic stimulation (TMS) for geriatric depression. [europepmc]
- Efficacy of Augmentation of Cognitive Behavioral Therapy With Transcranial Direct Current Stimulation for Depression: A Randomized Clinical Trial. [europepmc]
- Causal mapping of human brain function. [europepmc]
- The Problem and Potential of TMS' Infinite Parameter Space: A Targeted Review and Road Map Forward. [europepmc]
- Predicting the future of neuroimaging predictive models in mental health. [europepmc]
- Neuronavigation maximizes accuracy and precision in TMS positioning: Evidence from 11,230 distance, angle, and electric field modeling measurements. [europepmc]
- Assessing the mechanisms of brain plasticity by transcranial magnetic stimulation. [europepmc]
- A transdiagnostic network for psychiatric illness derived from atrophy and lesions. [europepmc]
- Functional Connectivity Mapping for rTMS Target Selection in Depression. [europepmc]
- Functional connectomics in depression: insights into therapies. [europepmc]
- The future of brain circuit-targeted therapeutics. [europepmc]
- Functional magnetic resonance imaging in schizophrenia: current evidence, methodological advances, limitations and future directions. [europepmc]
- Accelerated Theta Burst Stimulation: Safety, Efficacy, and Future Advancements. [europepmc]
- Frontostriatal salience network expansion in individuals in depression. [europepmc]
Related